JPH10165773A - Hollow yarn type blood treatment apparatus and its production - Google Patents
Hollow yarn type blood treatment apparatus and its productionInfo
- Publication number
- JPH10165773A JPH10165773A JP8329952A JP32995296A JPH10165773A JP H10165773 A JPH10165773 A JP H10165773A JP 8329952 A JP8329952 A JP 8329952A JP 32995296 A JP32995296 A JP 32995296A JP H10165773 A JPH10165773 A JP H10165773A
- Authority
- JP
- Japan
- Prior art keywords
- hollow fiber
- water
- processing apparatus
- washing
- fiber type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 81
- 210000004369 blood Anatomy 0.000 title claims abstract description 81
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 238000005406 washing Methods 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 86
- 239000012510 hollow fiber Substances 0.000 claims description 66
- 238000012545 processing Methods 0.000 claims description 59
- 239000012530 fluid Substances 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005273 aeration Methods 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 239000012528 membrane Substances 0.000 abstract description 17
- 239000012535 impurity Substances 0.000 abstract description 12
- 238000000926 separation method Methods 0.000 abstract description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000013557 residual solvent Substances 0.000 abstract description 3
- 238000012856 packing Methods 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 description 16
- 239000001301 oxygen Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
- 239000002504 physiological saline solution Substances 0.000 description 8
- 230000037452 priming Effects 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 238000007872 degassing Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000004382 potting Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004388 gamma ray sterilization Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- -1 polyacetate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、中空糸型血液処理
装置およびその製造方法に関するものであり、詳しくは
血液処理装置の充填水と洗浄方法に関するものであり、
更に詳しくは血液処理装置を効率よく洗浄することによ
り、前記血液処理装置内に残存する気泡量および不純物
を低減した中空糸型血液処理装置を提供するものであ
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hollow fiber type blood processing apparatus and a method for producing the same, and more particularly, to a filling water and a cleaning method for the blood processing apparatus.
More specifically, the present invention provides a hollow fiber type blood processing apparatus in which the amount of air bubbles and impurities remaining in the blood processing apparatus are reduced by efficiently cleaning the blood processing apparatus.
【0002】[0002]
【従来の技術】中空糸型血液処理装置は中空繊維状分離
膜を多数集合させた中空糸束を筒状のケース内に収納
し、中空糸束と筒状ケースとを接着固定するとともに筒
状ケースの両端部に血液導出入用キャップを具備したも
のであり、透析,濾過,濾過透析,血漿分離等に幅広く
使用されている。2. Description of the Related Art A hollow fiber type blood processing apparatus accommodates a hollow fiber bundle in which a large number of hollow fiber separation membranes are assembled in a cylindrical case, adheres and fixes the hollow fiber bundle to the cylindrical case, and forms a tube. It has caps for blood introduction and exit at both ends of the case, and is widely used for dialysis, filtration, filtration dialysis, plasma separation and the like.
【0003】中空糸型血液処理装置については大別し、
製造過程あるいは後処理工程に従い水または生体的無害
な水溶液で湿潤状態を保持したもの(以下湿式)と実質
乾燥状態のもの(以下乾式)と2種が存在している。近
年の傾向では第一に血液処理装置の残留物の低減/除去
を目的に通水洗浄を施すこと、第二に蒸気滅菌またはガ
ンマ線滅菌など滅菌処理から部材の劣化を防止する目的
で前者の湿式の中空糸型血液処理装置(特公昭55−2
3620号)が大半を占めるようになってきており、湿
式の中空糸型血液処理装置の充填液に関する研究も開示
されている(特開平4−338223号,特開平6−2
96838号,特開平7−328112号)。[0003] The hollow fiber type blood processing apparatus is roughly classified,
According to the production process or the post-treatment process, there are two types: one that is kept wet with water or a biologically harmless aqueous solution (hereinafter, wet type) and one that is substantially dry (hereinafter, dry type). In recent years, the first is to perform water washing for the purpose of reducing / removing the residue of the blood processing apparatus, and the second is the wet type for the purpose of preventing deterioration of members from sterilization such as steam sterilization or gamma ray sterilization. Hollow fiber blood treatment device (Japanese Patent Publication No. 55-2)
No. 3620), and studies on a filling solution for a wet type hollow fiber type blood processing apparatus have been disclosed (JP-A-4-338223, JP-A-6-2).
96838, JP-A-7-328112).
【0004】また中空糸型血液処理装置の洗浄方法に関
してはこれまで残留物質の除去を目的に例えば特開昭6
0−68862号,特開昭56−15756号,特開平
7−22683号や特公平7−29030号等に開示の
如く洗浄水の流量や温度条件の検討がなされてきた。A method of cleaning a hollow fiber type blood processing apparatus has been described so far in order to remove residual substances.
As disclosed in Japanese Patent Application No. 0-68862, JP-A-56-15756, JP-A-7-22683, and JP-B-7-29030, the flow rate and temperature conditions of washing water have been studied.
【0005】中空糸型血液処理装置の使用に際しては、
乾式の血液処理装置については主に装置内の残留物質除
去と気泡除去および生理食塩液の充填のために、湿式の
血液処理装置については主に気泡除去と充填液の生理食
塩液置換のために、生理食塩液にてプライミングなる使
用前処理を行っている。When using a hollow fiber type blood processing apparatus,
Dry blood processing equipment is mainly used for removing residual substances and air bubbles in the equipment and filling with physiological saline, and wet blood processing equipment is mainly used for removing air bubbles and replacing the filling liquid with physiological saline. Priming with physiological saline solution.
【0006】血液処理装置内に溶出物または不純物が残
留している場合は、プライミング処理には手間のかかる
ことは言うまでもないが、乾式の血液処理装置は残留物
の除去のためプライミングの面においても時間と生理食
塩液量をより費やし使用者側の作業効率に課題があり、
湿式の血液処理装置においても水の充填度が低いと気泡
除去のために労力を費やし作業効率改善の余地があっ
た。[0006] When eluting substances or impurities remain in the blood processing apparatus, it is needless to say that the priming process is troublesome. However, the dry type blood processing apparatus is also priming in order to remove the residue. There is a problem in the work efficiency on the user side by spending more time and saline volume,
Even in a wet blood treatment apparatus, if the degree of filling of water is low, there is room for improving the working efficiency by consuming labor for removing bubbles.
【0007】[0007]
【発明が解決しようとする課題】本発明は、上記の問題
点を直視し中空糸型血液処理装置内に残存する気泡量お
よび不純物を低減した血液処理装置と中空糸型血液処理
装置内の残留物を効率よく洗浄する製造方法とを提供す
ることにある。SUMMARY OF THE INVENTION In view of the above problems, the present invention is directed to a blood processing apparatus in which the amount of air bubbles and impurities remaining in a hollow fiber type blood processing apparatus are reduced and a residual amount in a hollow fiber type blood processing apparatus is reduced. Another object of the present invention is to provide a manufacturing method for efficiently cleaning an object.
【0008】[0008]
【課題を解決するための手段】本発明の中空糸型流体処
理装置は、水または生体的無害な水溶液で充填密閉され
ている中空糸型流体処理装置において、充填液中に残留
する中空糸材料の良溶媒の濃度が2ppm以下であり、
かつ中空糸型流体処理装置内に存在する空隙率が3%以
下であることを特徴とする。SUMMARY OF THE INVENTION A hollow fiber type fluid treatment apparatus according to the present invention is a hollow fiber type fluid treatment apparatus which is filled with water or a biologically harmless aqueous solution and is sealed. The concentration of the good solvent is 2 ppm or less,
Further, the porosity present in the hollow fiber type fluid treatment device is 3% or less.
【0009】本発明の製造方法は、中空糸型流体処理装
置を洗浄温度における飽和溶存濃度未満に脱気した水ま
たは生体的無害な水溶液で洗浄し充填密閉することを特
徴とする。さらには血液処理装置内を二酸化炭素で通気
した後に行うことが好ましく、また中空内部の通水と中
空内部から中空外部におこなう濾過通水とを併用し洗浄
するのが好ましい。[0009] The production method of the present invention is characterized in that the hollow fiber type fluid treatment apparatus is washed with water or a biologically harmless aqueous solution degassed to a concentration lower than the saturated dissolved concentration at the washing temperature and filled and sealed. Further, it is preferable to perform the cleaning after aeration of the inside of the blood processing apparatus with carbon dioxide, and it is also preferable to perform cleaning by using water passing through the hollow interior and filtration water passing from the hollow interior to the hollow exterior.
【0010】また、洗浄水として電導度で20μS/c
m以下または40℃〜95℃の高温の水または生体的無
害な水溶液を使用することによりさらに効果を発揮する
ことができる。[0010] Further, as cleaning water, the conductivity is 20 μS / c.
m or a high-temperature water of 40 ° C. to 95 ° C. or a biologically harmless aqueous solution can further exert the effect.
【0011】また、過酸化水素を含有する水溶液で充填
密閉し放射線滅菌をすることにより中空糸型流体処理装
置内に残存する菌の滅菌を行うのが好ましい。It is preferable to sterilize the bacteria remaining in the hollow fiber type fluid treatment apparatus by filling and sealing with an aqueous solution containing hydrogen peroxide and performing radiation sterilization.
【0012】[0012]
【発明の実施の形態】以下、本発明の中空糸型血液流体
処理装置およびその製造方法について、図面も用い詳細
に説明する。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The hollow fiber type blood fluid treatment apparatus of the present invention and a method for manufacturing the same will be described in detail with reference to the drawings.
【0013】本発明における中空糸型血液処理装置の一
例を断面図として図1に示す。中空糸型血液処理装置は
選択透過性を有する多数の繊維状分離膜2を用いた血液
処理装置であるが、分離膜としては中空糸形状,材質と
も特に限定するものではないが、材質としては例えばセ
ルロース系,ポリメチルメタアクリレート系,ポリアク
リロニトリル系,ポリアセテート系,ポリスルホン系,
エチレンビニルアルコール系の膜が好適に使用される。FIG. 1 is a sectional view showing an example of a hollow fiber type blood processing apparatus according to the present invention. The hollow fiber type blood processing apparatus is a blood processing apparatus using a large number of selectively permeable fibrous separation membranes 2. The separation membrane is not particularly limited in hollow fiber shape and material, but may be any material. For example, cellulose, polymethyl methacrylate, polyacrylonitrile, polyacetate, polysulfone,
An ethylene vinyl alcohol-based film is preferably used.
【0014】これら中空糸の分離膜を製膜するに際して
は、一般的に中空糸材料を良溶媒に溶解し紡糸する。良
溶媒としてはジメチルアセトアミド,ジメチルスルホキ
シド,ジメチルホルムアミドやN−メチルピロリドンな
ど多種の溶媒が使用できる。In forming such a hollow fiber separation membrane, the hollow fiber material is generally dissolved in a good solvent and spun. Various solvents such as dimethylacetamide, dimethylsulfoxide, dimethylformamide and N-methylpyrrolidone can be used as good solvents.
【0015】また、中空糸型血液処理装置の製造工程に
おいて、これら中空糸材料の良溶媒は不純物として洗浄
等で除去する必要がある。洗浄効果の一指標として、中
空糸型血液処理装置中の残留溶媒濃度を測定することが
でき、残留溶媒濃度は2ppm以下、好ましくは0.5
ppm以下にする。In the manufacturing process of the hollow fiber type blood processing apparatus, it is necessary to remove the good solvent of these hollow fiber materials as impurities by washing or the like. As an index of the cleaning effect, the residual solvent concentration in the hollow fiber type blood processing apparatus can be measured, and the residual solvent concentration is 2 ppm or less, preferably 0.5 ppm or less.
ppm or less.
【0016】図1において、繊維状分離膜2は筒状ケー
ス1に収納されポッティング材3により接着固定され、
血液接触面5a,5bで中空の開口面を得ている。筒状
ケース1の両端部には血液導出入用キャップ4a,4b
を有しており、処理液側にも導出入口6a,6bを有し
ている。In FIG. 1, a fibrous separation membrane 2 is housed in a cylindrical case 1 and fixedly adhered by a potting material 3.
A hollow opening surface is obtained by the blood contact surfaces 5a and 5b. At both ends of the cylindrical case 1 are caps 4a and 4b for blood introduction and introduction.
The processing liquid also has outlets 6a and 6b.
【0017】中空糸型血液処理装置としては、血液処理
装置内が水または生体的無害な水溶液で密閉充填されて
いる状態のものであり、図示しない栓により血液導出入
口および処理液導出入口で密閉状態に保持されている。The hollow fiber type blood processing apparatus is a state in which the inside of the blood processing apparatus is hermetically filled with water or a biologically harmless aqueous solution, and is sealed at the blood outlet and the processing liquid outlet by plugs (not shown). Held in state.
【0018】この中空糸型流体処理装置の使用に際して
は、まず使用前処理(プライミング処理)として生理食
塩液を流体導入口より導入し中空糸開口面の多数の中空
糸膜へ分配され、中空糸内を通液したのち血液導出口よ
り外部へ排出される。このとき中空内部の空隙,気泡ま
たは既充填液は洗い流され生理食塩液で置換し、被処理
液である血液を導入する。血液処理終了時には、プライ
ミングと同様の操作により生理食塩液により血液処理装
置内の血液を体内に返血する。When using this hollow fiber type fluid treatment apparatus, first, as a pre-treatment (priming treatment), a physiological saline solution is introduced from a fluid inlet and distributed to a large number of hollow fiber membranes at the opening surface of the hollow fiber. After passing through the inside, it is discharged from the blood outlet to the outside. At this time, voids, air bubbles or the already-filled liquid in the hollow interior are washed away and replaced with a physiological saline solution, and blood as a liquid to be treated is introduced. At the end of the blood processing, the blood in the blood processing apparatus is returned to the body with physiological saline by the same operation as priming.
【0019】血液処理装置内に不純物または気泡が残存
していると、プライミング処理の為の生理食塩液の洗
浄,置換が十分にできないといった問題を生じる。不純
物が残留した場合には血液内に混入する恐れがあり、気
泡が残存した場合には中空内にエアーロックが生じ、中
空糸膜の有効活用ができず性能低下を引き起こしたり、
長時間の血液処理中に凝血を起こし全血液を体内に返血
できない問題(以下残血という)を誘発する。If impurities or bubbles remain in the blood processing apparatus, there arises a problem that washing and replacement of physiological saline for priming cannot be sufficiently performed. If impurities remain, they may be mixed into the blood.If air bubbles remain, air locks occur in the hollow, and the hollow fiber membrane cannot be used effectively, causing performance degradation,
During prolonged blood treatment, blood clots occur, causing a problem that whole blood cannot be returned to the body (hereinafter referred to as residual blood).
【0020】本発明の中空糸型血液処理装置は不純物の
低減および気泡残存量の低減を図るため、洗浄水として
洗浄温度における飽和溶存濃度未満に脱気し、さらには
洗浄水中の電導度を20μS/cm以下にして、さらに
は40℃〜95℃の高温水を用いることが好ましい。The hollow fiber blood treatment apparatus of the present invention degass the washing water to a concentration lower than the saturated dissolved concentration at the washing temperature to reduce impurities and the amount of remaining bubbles, and furthermore, reduces the conductivity in the washing water to 20 μS. / Cm or less, and more preferably high-temperature water at 40 ° C to 95 ° C is used.
【0021】ここで、空隙率とは湿式の中空糸型血液処
理装置の残存気泡量をしめす指標であり、{(満水重
量)−(洗浄充填後の重量)}/(満水重量)であらわ
すものであり、(満水重量)は中空糸の内側・外側膜,
中空糸膜内の空孔にいたる中空糸型血液処理装置の空隙
部を全て液密に充填した時の中空糸型血液処理装置の重
量(栓状部材も含む)のことである。満水重量は例え
ば、中空糸型血液処理装置を500ml/分の流量で3
日間常温の水で通水し、空隙部を液密状態にした後に重
量を測定することにより簡便に求めることができる。空
隙率は3%以下が好ましく、より好ましくは1%以下に
抑えることがよい。Here, the porosity is an index indicating the amount of residual air bubbles in a wet-type hollow fiber type blood processing apparatus, and is expressed by {(weight filled with water)-(weight after washing and filling)} / (weight filled with water). Where (full water weight) is the inner and outer membrane of the hollow fiber,
It is the weight (including the plug-like member) of the hollow fiber type blood processing apparatus when all the voids of the hollow fiber type blood processing apparatus leading to the holes in the hollow fiber membrane are filled in a liquid-tight manner. The full-water weight is, for example, 3 with a hollow fiber type blood processing apparatus at a flow rate of 500 ml / min.
It can be easily obtained by measuring the weight after passing water through room-temperature water for a day to make the gap liquid-tight. The porosity is preferably 3% or less, more preferably 1% or less.
【0022】また、溶存酸素濃度とは、液中に溶解して
いる酸素濃度を示すもので、25℃、1気圧下での飽和
溶存酸素濃度は約8.1ppmであるが、本願では次に
示す一般的な手段により水中の溶存酸素を除去すること
ができる。 沸点まで加熱し、密閉下で冷却する方法。 蒸気圧まで減圧する方法。 不活性ガスによりバブリング置換する方法。 触媒との接触反応を利用した方法。 膜によるガス透過を利用した膜分離方法。The dissolved oxygen concentration refers to the concentration of oxygen dissolved in the liquid, and the saturated dissolved oxygen concentration at 25 ° C. and 1 atm is about 8.1 ppm. The dissolved oxygen in the water can be removed by the general means shown. A method of heating to the boiling point and cooling in a sealed state. A method of reducing the pressure to the vapor pressure. A method of bubbling displacement with an inert gas. A method utilizing a contact reaction with a catalyst. A membrane separation method using gas permeation through a membrane.
【0023】本発明にかかる充填水を得るには、上記の
手法に限定されるものではない。量的かつ連続的に得る
には上記手法,,が適用できる。またここに挙げ
た手法のうち,,では、溶存酸素に限らず溶存窒
素といった溶存気体を除去(脱気)することができ、本
発明の目的をより効果的に実現することができる。総合
し、上記手法の,が好ましく用いられるもので、上
記の手法の組み合わせでも可能である。The method for obtaining the filling water according to the present invention is not limited to the above method. The above method can be applied to obtain quantitatively and continuously. Further, among the techniques mentioned here, in, it is possible to remove (degas) not only dissolved oxygen but also dissolved gas such as dissolved nitrogen, and the object of the present invention can be realized more effectively. Overall, the above method is preferably used, and a combination of the above methods is also possible.
【0024】溶存気体を低く抑えた水で洗浄充填するこ
とにより、血液処理装置内の気泡が完全に除去でき、残
存気泡量が低減できる。さらに、中空糸膜厚内の微細孔
内の気泡が除去され液密状態になることから物質移動が
容易になり、洗浄効率も向上する。By washing and filling with water in which the dissolved gas is kept low, bubbles in the blood processing apparatus can be completely removed, and the amount of remaining bubbles can be reduced. Further, since air bubbles in the micropores in the hollow fiber film thickness are removed and a liquid-tight state is obtained, mass transfer is facilitated, and cleaning efficiency is improved.
【0025】血液処理装置は通常滅菌処理を施すが、ハ
ウジング部材の耐熱性の問題や滅菌時の残留物が残らず
安全性にメリットがあることからガンマ線滅菌が広く使
用されているが、本発明の如く脱酸素処理を行った水を
充填する場合では、ガンマ線照射時の酸素ラジカルが少
なく、滅菌効果が減少する可能性がある。すなわち菌を
死滅に至らす必要照射線量が上がってしまう(D値が上
がってしまう)可能性がある。この場合、本願に記載の
とおり、過酸化水素水を添加し、ガンマ線照射すること
によりD値の上昇を抑えることができる。また、過酸化
水素水は、血液処理装置洗浄後からガンマ線滅菌処理ま
での保管中の静菌効果ももたらす。Although the blood processing apparatus is usually sterilized, gamma ray sterilization is widely used because there is a problem in heat resistance of the housing member and there is an advantage in safety because there is no residue at the time of sterilization. In the case of filling with deoxidized water as described above, there is a possibility that the amount of oxygen radicals at the time of gamma ray irradiation is small and the sterilization effect is reduced. That is, there is a possibility that the required irradiation dose to kill the bacteria increases (the D value increases). In this case, as described in the present application, an increase in the D value can be suppressed by adding a hydrogen peroxide solution and irradiating with gamma rays. The aqueous hydrogen peroxide also has a bacteriostatic effect during storage from washing of the blood processing apparatus to gamma sterilization.
【0026】本発明のもう一つの要件として挙げられて
いる40℃〜95℃の高温水での洗浄では洗浄水中に気
泡が顕在化する故、気体の水に対する溶解度を考慮に加
える必要がある。溶存酸素濃度の場合で、40℃では6
ppm以下に、50℃では5.5ppm以下に、60℃
では4.5ppm以下に、80℃では2.5ppm以下
にすることが好ましい。In washing with high-temperature water at 40 ° C. to 95 ° C., which is another requirement of the present invention, air bubbles become apparent in the washing water. Therefore, it is necessary to take into account the solubility of gas in water. In the case of dissolved oxygen concentration,
ppm or less, at 50 ° C 5.5 ppm or less, 60 ° C
Is preferably 4.5 ppm or less at 80 ° C.
【0027】電導度は洗浄水の精製度の一つの指標であ
り、蒸留水またはイオン交換水または逆浸透膜で処理し
たRO水を用いることにより本願の要件を達成すること
ができる。The electric conductivity is one index of the degree of purification of the washing water, and the requirements of the present invention can be achieved by using distilled water, ion-exchanged water, or RO water treated with a reverse osmosis membrane.
【0028】洗浄水製造装置の一例を図2に示す。FIG. 2 shows an example of the washing water producing apparatus.
【0029】また、生体的無害な水溶液とは、例えば蒸
留水,イオン交換水,RO水を主成分にした生理食塩液
やグリセリン液などであるが特に限定するものではな
い。The biologically harmless aqueous solution is, for example, a physiological saline solution or a glycerin solution containing distilled water, ion-exchanged water or RO water as a main component, but is not particularly limited.
【0030】次に、洗浄水にて血液処理装置を通水洗浄
する際には、予め、血液処理装置内の空気を水への溶解
度の高い二酸化炭素で置換しておくことにより、残存気
泡量がさらに低減でき、洗浄効率をよりいっそう向上さ
せることができる。Next, when the blood processing apparatus is passed through the cleaning apparatus with the washing water, the air in the blood processing apparatus is replaced with carbon dioxide having a high solubility in water in advance, so that the remaining air bubbles are reduced. Can be further reduced, and the cleaning efficiency can be further improved.
【0031】洗浄方法については、中空内部と中空外部
に洗浄水を通水し洗浄する方法、または中空内部から中
空外部に行う濾過通水洗浄方法といったすでに公知の洗
浄を用いても良いが、前者の洗浄方法では洗浄水が多く
必要となり、後者の洗浄方法では中空糸のショートパス
やポッティング接着部の洗浄が不十分となる問題が生じ
る可能性がある。よって、図3に示す中空内部の通水洗
浄と図4に示す濾過通水洗浄を併用する方法が有効であ
る。ある間隔で中空内部の通水洗浄と濾過通水洗浄を複
数回交互に切替て洗浄してもよい。As for the washing method, known washing methods such as a method of washing by passing washing water through the hollow interior and the outside of the hollow, or a method of filtering and passing water from the inside of the hollow to the outside of the hollow may be used. The cleaning method of (1) requires a large amount of cleaning water, and the latter cleaning method may cause a problem that the short path of the hollow fiber and the cleaning of the potting bonding portion become insufficient. Therefore, it is effective to use a combination of the water washing of the hollow interior shown in FIG. 3 and the filtration water washing shown in FIG. At a certain interval, washing may be performed by alternately switching between the water washing and the filtration water washing of the hollow interior a plurality of times.
【0032】最後に、血液処理装置内は、水または水溶
液が充填された後に栓状部材で、開口部を密閉すること
により、湿潤状態が保持される。このとき、血液処理装
置内の空隙量を最小限に抑え密閉することが好ましく、
また密閉部材としては形状材質とも限定しないが、酸素
の透過性の高い材質は本発明の効果が十分に得られない
ため避けることが望ましい。Finally, the inside of the blood processing apparatus is kept wet by closing the opening with a plug-like member after being filled with water or an aqueous solution. At this time, it is preferable that the amount of voids in the blood processing apparatus be minimized and sealed,
Further, the sealing member is not limited to a shape material, but a material having high oxygen permeability is desirably avoided because the effect of the present invention cannot be sufficiently obtained.
【0033】[0033]
【実施例】内径200μm,外径280μm,中空糸本
数13056本、有効膜面積1.6m2のポリスルホン
系の中空糸束を筒状のケースに収納したのち、ポリウレ
タン系樹脂を遠心下で注入ポッティングし、筒状ケース
と中空糸束の両端をそれぞれ接着固定し、両端に導出入
用キャップを取り付け、実験用の中空糸型血液処理装置
を得て、次に洗浄を行った。満水重量は、中空糸型血液
処理装置を500ml/minにて3日間常温の水で通
水し栓をしたものの、重量を測定することにより求め
た。このときの理論満水重量は579.4gであった。EXAMPLE A polysulfone-based hollow fiber bundle having an inner diameter of 200 μm, an outer diameter of 280 μm, a number of hollow fibers of 13056, and an effective membrane area of 1.6 m 2 was housed in a cylindrical case, and then polyurethane resin was injected under centrifugation. Then, both ends of the tubular case and the hollow fiber bundle were bonded and fixed, respectively, and caps for drawing in and out were attached to both ends to obtain an experimental hollow fiber type blood processing apparatus, and then washed. The full water weight was determined by measuring the weight of a hollow fiber blood treatment apparatus at 500 ml / min for 3 days with normal temperature water and plugging. The theoretical full water weight at this time was 579.4 g.
【0034】中空糸型血液処理装置の洗浄は、図2に示
す洗浄水製造装置にて処理した水にて実施した。このと
き電導度は11μS/cmであった。脱気装置としては
市販の膜型脱気装置(三浦工業株式会社製、DOR−3
000C)を用い脱気を行った。脱気度の指標として溶
存酸素濃度を測定し所望の濃度になるように調整した。
温度は熱交換にて所望の温度条件に設定した。また、過
酸化水素濃度は30ppmにするよう添加した。洗浄に
ついて、時間はいずれの場合も35分間に統一し洗浄を
行い、洗浄水の通水前には二酸化炭素を血液処理装置内
に通気した後、洗浄を開始した。条件をそれぞれ変更し
実施した。Washing of the hollow fiber type blood treatment apparatus was performed with water treated by the washing water producing apparatus shown in FIG. At this time, the conductivity was 11 μS / cm. As a deaerator, a commercially available membrane type deaerator (manufactured by Miura Kogyo Co., Ltd., DOR-3)
000C). The dissolved oxygen concentration was measured as an index of the degree of degassing and adjusted to a desired concentration.
The temperature was set to a desired temperature condition by heat exchange. Further, the hydrogen peroxide concentration was added so as to be 30 ppm. Regarding the washing, the washing time was set to 35 minutes in each case, and the washing was started after passing carbon dioxide into the blood processing apparatus before passing the washing water. The conditions were changed and implemented.
【0035】洗浄,充填した中空糸型血液処理装置で、
次の評価を行った。 気泡の除去量の測定:血液処理装置の重量を計り、水
の充填量を測定した。重量の重いものほど気泡が除去さ
れているものと判断した。洗浄前の重量も測定し対応と
した。 不純物の除去量の測定:血液処理装置を25kGyの
ガンマ線照射後に、充填水を抜き取り、GC−MSにて
充填水に残留したポリスルホン系中空糸材料の良溶媒濃
度(ジメチルアセトアミド(DMAc))を測定した。
DMAc濃度の低いものほど不純物が少ないと判断し
た。A hollow fiber type blood processing apparatus which has been washed and filled,
The following evaluation was performed. Measurement of removal amount of air bubbles: The blood processing apparatus was weighed, and the amount of filled water was measured. The heavier the weight, the more bubbles were determined to be removed. The weight before washing was also measured and handled. Measurement of the amount of impurities removed: After irradiating the blood processing apparatus with gamma rays of 25 kGy, the filling water was extracted, and the good solvent concentration (dimethylacetamide (DMAc)) of the polysulfone-based hollow fiber material remaining in the filling water was measured by GC-MS. did.
It was determined that the lower the DMAc concentration, the less the impurities.
【0036】実施例1 溶存酸素濃度が0.5ppmになるように脱気し、温度
を90℃に加温し、洗浄水とした。洗浄方法として、中
空内の通水洗浄を3分間実施した後、続いて濾過通水洗
浄を3分間実施する。これを5回実施し、計30分間洗
浄を行った後、5分間30℃の洗浄水にて冷却し、栓を
した。Example 1 Degassing was performed so that the concentration of dissolved oxygen became 0.5 ppm, and the temperature was raised to 90 ° C. to obtain washing water. As a washing method, after washing with water in the hollow for 3 minutes, subsequently, washing with water through filtration is performed for 3 minutes. This was carried out five times, and after washing for a total of 30 minutes, the mixture was cooled with washing water at 30 ° C. for 5 minutes and stoppered.
【0037】実施例2 溶存酸素濃度が2ppmになるように脱気し、温度を8
0℃に加温し、洗浄水とした。洗浄方法として、中空内
の通水洗浄を3分間実施した後、続いて濾過通水洗浄を
3分間実施する。これを5回実施し、計30分間洗浄を
行った後、5分間30℃の洗浄水にて冷却し、栓をし
た。Example 2 Degassing was performed so that the dissolved oxygen concentration became 2 ppm,
The mixture was heated to 0 ° C. to obtain washing water. As a washing method, after washing with water in the hollow for 3 minutes, subsequently, washing with water through filtration is performed for 3 minutes. This was carried out five times, and after washing for a total of 30 minutes, the mixture was cooled with washing water at 30 ° C. for 5 minutes and stoppered.
【0038】実施例3 溶存酸素濃度が5ppmになるように脱気し、温度を5
0℃に加温し、洗浄水とした。洗浄方法として、中空内
の通水洗浄を3分間実施した後、続いて濾過通水洗浄を
3分間実施する。これを5回実施し、計30分間洗浄を
行った後、5分間30℃の洗浄水にて冷却し、栓をし
た。Example 3 Degassing was performed so that the dissolved oxygen concentration became 5 ppm, and the temperature was reduced to 5 ppm.
The mixture was heated to 0 ° C. to obtain washing water. As a washing method, after washing with water in the hollow for 3 minutes, subsequently, washing with water through filtration is performed for 3 minutes. This was carried out five times, and after washing for a total of 30 minutes, the mixture was cooled with washing water at 30 ° C. for 5 minutes and stoppered.
【0039】比較例1 脱気操作をせずに、温度を40℃に加温し、洗浄水とし
た。洗浄方法として、中空内の通水洗浄を3分間実施し
た後、続いて濾過通水洗浄を3分間実施する。これを5
回実施し、計30分間洗浄を行った後、5分間30℃の
洗浄水にて冷却し、栓をした。COMPARATIVE EXAMPLE 1 The temperature was raised to 40 ° C. without performing deaeration operation, and used as washing water. As a washing method, after washing with water in the hollow for 3 minutes, subsequently, washing with water through filtration is performed for 3 minutes. This is 5
After washing for a total of 30 minutes, the system was cooled with washing water at 30 ° C. for 5 minutes and stoppered.
【0040】比較例2 脱気操作はせず、温度を80℃に加温し、洗浄水とし
た。洗浄方法として、中空内の通水洗浄を3分間実施し
た後、続いて濾過通水洗浄を3分間実施する。これを5
回実施し、計30分間洗浄を行った後、5分間30℃の
洗浄水にて冷却し、栓をした。Comparative Example 2 The temperature was raised to 80 ° C. without deaeration, and used as washing water. As a washing method, after washing with water in the hollow for 3 minutes, subsequently, washing with water through filtration is performed for 3 minutes. This is 5
After washing for a total of 30 minutes, the system was cooled with washing water at 30 ° C. for 5 minutes and stoppered.
【0041】結果を下表にまとめて示す。 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 実験番号 血液処理装置の重量A 空隙率 DMAc濃度 [g] [%] [ppm] −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 実施例1 577.1 0.4 0.08 実施例2 577.8 0.3 0.15 実施例3 578.2 0.2 1.50 比較例1 573.3 1.1 2.60 比較例2 561.3 3.1 0.55 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 注: 空隙率[%]=(579.4−A)/579.4×100The results are summarized in the following table. -------------------------------------------------------Experiment No. Weight of blood processing apparatus A Porosity DMAc concentration [g] [%] [Ppm] −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− Example 1 577.1 0.4 0.08 Example 2 577.8 0.3 0.15 Example 3 578.2 0.2 1.50 Comparative Example 1 573.3 1.1 2.60 Comparative Example 2 561.3 3.1 0.55 ------ −−−−−−−−−−−−−−−−−−−−−−−−−−−− Note: Porosity [%] = (579.4-A) /579.4×100
【0042】[0042]
【発明の効果】以上詳細に説明したように、本発明の中
空糸型血液処理装置およびその製造方法によれば血液処
理装置内に残存する気泡量および不純物を低減できる。As described above in detail, according to the hollow fiber type blood processing apparatus and the method of manufacturing the same of the present invention, the amount of air bubbles and impurities remaining in the blood processing apparatus can be reduced.
【図1】中空糸型流体処理装置の一例を示す断面図FIG. 1 is a cross-sectional view showing an example of a hollow fiber type fluid treatment device.
【図2】洗浄水製造装置の一例を示す概略フロー図。FIG. 2 is a schematic flow chart showing an example of a cleaning water production device.
【図3】中空糸型血液処理装置の中空内部の通水洗浄に
おける洗浄水の流路を示す説明図FIG. 3 is an explanatory view showing a flow path of washing water in washing water through the inside of the hollow of the hollow fiber type blood processing apparatus.
【図4】中空糸型血液処理装置の濾過通水洗浄における
洗浄水の流路を示す説明図FIG. 4 is an explanatory diagram showing a flow path of washing water in filtration water washing of a hollow fiber type blood processing apparatus.
【符号の説明】 1 :筒状ケース 2 :中空糸膜 3 :ポッティング材 4a:血液導入用キャップ 4b:血液導出用キャップ 5a,b:開口面 6a,b:処理液導出入用ノズル 7 :プレフィルター 8 :脱気装置 9 :RO膜 10:熱交換器 11:中空糸型流体処理装置[Description of Signs] 1: Cylindrical case 2: Hollow fiber membrane 3: Potting material 4a: Cap for blood introduction 4b: Cap for blood derivation 5a, b: Opening surface 6a, b: Nozzle for treatment liquid derivation 7: Pre Filter 8: Degassing device 9: RO membrane 10: Heat exchanger 11: Hollow fiber type fluid treatment device
Claims (8)
されている中空糸型流体処理装置において、充填液中に
残留する中空糸材料の良溶媒の濃度が2ppm以下であ
り、かつ中空糸型流体処理装置内に存在する空隙率が3
%以下であることを特徴とする中空糸型流体処理装置。1. A hollow fiber type fluid treatment apparatus filled and sealed with water or a biologically harmless aqueous solution, wherein the concentration of a good solvent in a hollow fiber material remaining in the filling liquid is 2 ppm or less, and The porosity present in the fluid treatment device is 3
% Or less.
ることを特徴とする請求項1記載の中空糸型流体処理装
置。2. The hollow fiber type fluid treatment apparatus according to claim 1, wherein said hollow fiber material is a polysulfone resin.
飽和溶存濃度未満に脱気した水または生体的無害な水溶
液で洗浄し充填密閉することを特徴とする中空糸型血液
処理装置の製造方法。3. A method for manufacturing a hollow fiber type blood processing apparatus, comprising washing the hollow fiber type fluid processing apparatus with water or a biologically harmless aqueous solution degassed to a concentration lower than the saturated dissolved concentration at the washing temperature, filling the closed state, and sealing. .
cm以下であることを特徴とする請求項3記載の中空糸
型血液処理装置の製造方法。4. The method according to claim 1, wherein the water or the aqueous solution has an electric conductivity of 20 μS /
The method for producing a hollow fiber type blood processing apparatus according to claim 3, wherein the diameter is not more than cm.
害な水溶液で洗浄することを特徴とする請求項3記載の
中空糸型血液処理装置の製造方法。5. The method for producing a hollow fiber type blood processing apparatus according to claim 3, wherein the apparatus is washed with high-temperature water at 40 ° C. to 95 ° C. or a biologically harmless aqueous solution.
洗浄することを特徴とする請求項3記載の中空糸型血液
処理装置の製造方法。6. The method for producing a hollow fiber type blood processing apparatus according to claim 3, wherein the blood processing apparatus is washed after aeration with carbon dioxide.
放射線滅菌することを特徴とする請求項3記載の中空糸
型血液処理装置の製造方法。7. The method for producing a hollow fiber type blood processing apparatus according to claim 3, wherein the apparatus is filled with an aqueous solution containing hydrogen peroxide, sealed, and sterilized by radiation.
おこなう濾過通水とを併用し洗浄することを特徴とする
中空糸型流体処理装置の製造方法。8. A method for manufacturing a hollow fiber type fluid treatment apparatus, wherein washing is carried out by using water passing through the hollow interior and filtration water passing from the hollow interior to the hollow exterior.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8329952A JPH10165773A (en) | 1996-12-10 | 1996-12-10 | Hollow yarn type blood treatment apparatus and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8329952A JPH10165773A (en) | 1996-12-10 | 1996-12-10 | Hollow yarn type blood treatment apparatus and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10165773A true JPH10165773A (en) | 1998-06-23 |
Family
ID=18227106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8329952A Pending JPH10165773A (en) | 1996-12-10 | 1996-12-10 | Hollow yarn type blood treatment apparatus and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10165773A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000218140A (en) * | 1998-11-27 | 2000-08-08 | Toray Ind Inc | Module incorporating membrane and method of manufacturing the same |
WO2006041125A1 (en) * | 2004-10-15 | 2006-04-20 | Nipro Corporation | Method of hemopurifier sterilization and hemopurifier package |
WO2006104082A1 (en) * | 2005-03-28 | 2006-10-05 | Toyo Boseki Kabushiki Kaisha | Packaged module for blood purification and method of sterilizing the same |
US9050410B2 (en) | 2004-10-15 | 2015-06-09 | Nipro Corporation | Blood purifier and blood purifier package |
US9067178B2 (en) | 2004-12-22 | 2015-06-30 | Nipro Corporation | Blood purifier package and process for manufacturing the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5615756A (en) * | 1979-07-19 | 1981-02-16 | Nissho Kk | Filling method of blood flow path for artificial internal organ |
JPH05317416A (en) * | 1992-05-21 | 1993-12-03 | Dainippon Ink & Chem Inc | Priming method |
-
1996
- 1996-12-10 JP JP8329952A patent/JPH10165773A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5615756A (en) * | 1979-07-19 | 1981-02-16 | Nissho Kk | Filling method of blood flow path for artificial internal organ |
JPH05317416A (en) * | 1992-05-21 | 1993-12-03 | Dainippon Ink & Chem Inc | Priming method |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000218140A (en) * | 1998-11-27 | 2000-08-08 | Toray Ind Inc | Module incorporating membrane and method of manufacturing the same |
WO2006041125A1 (en) * | 2004-10-15 | 2006-04-20 | Nipro Corporation | Method of hemopurifier sterilization and hemopurifier package |
US9050410B2 (en) | 2004-10-15 | 2015-06-09 | Nipro Corporation | Blood purifier and blood purifier package |
US9056280B2 (en) | 2004-10-15 | 2015-06-16 | Nipro Corporation | Method for sterilizing blood purifier and blood purifier package |
US9987409B2 (en) | 2004-10-15 | 2018-06-05 | Nipro Corporation | Blood purifier and blood purifier package |
US10137234B2 (en) | 2004-10-15 | 2018-11-27 | Nipro Corporation | Method for sterilizing blood purifier and blood purifier package |
US9067178B2 (en) | 2004-12-22 | 2015-06-30 | Nipro Corporation | Blood purifier package and process for manufacturing the same |
US9987408B2 (en) | 2004-12-22 | 2018-06-05 | Nipro Corporation | Blood purifier package and process for manufacturing the same |
WO2006104082A1 (en) * | 2005-03-28 | 2006-10-05 | Toyo Boseki Kabushiki Kaisha | Packaged module for blood purification and method of sterilizing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS58163490A (en) | Method and apparatus for purification of water | |
JPH10165773A (en) | Hollow yarn type blood treatment apparatus and its production | |
JPH04176303A (en) | Method for removing gas dissolved in liquid | |
JP2000296318A (en) | Polysulfone-base blood treatment module | |
JPH0768103A (en) | Membrane deaerating method | |
JP2009183804A (en) | Method for producing hydrophilic microporous membrane | |
JPS62155906A (en) | How to clean hollow fiber filtration module | |
JP4596171B2 (en) | Blood purifier | |
WO2016182015A1 (en) | Porous hollow fiber membrane and manufacturing method therefor | |
JP2006288414A (en) | Polysulfone hollow fiber membrane blood purifier | |
JP3354257B2 (en) | Oil-water separation method and oil-water separation device | |
JPWO2016111320A1 (en) | Filter, body cavity fluid processing system, and body cavity fluid processing method | |
JPS62216695A (en) | Method and apparatus for producing pure water | |
JPS62227492A (en) | Method and apparatus for making pure water | |
JPH057049B2 (en) | ||
JPS60248203A (en) | Filter module comprising hollow yarn membrane | |
JPS5837037B2 (en) | Purified water production method | |
JP3409863B2 (en) | Removal device for dissolved organic matter in water | |
JP2000210544A (en) | Production of semipermeable membrane | |
JP2781012B2 (en) | Degassing of dissolved gas from liquid | |
JP2001309974A (en) | Hollow string type hemodialyzer | |
EP2813252B1 (en) | Filter device for blood and similar body fluids | |
JPH05208121A (en) | Method for hydrophilizing porous membrane | |
JP2977873B2 (en) | Hollow fiber blood processing apparatus and method for producing the same | |
JPS62221489A (en) | Method for making pure water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040323 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040512 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050111 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050310 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060620 |